Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc. demonstrates significant upside potential in its stock, with a current enterprise value of approximately $430 million, and projections indicating an 8-10x increase in share price contingent upon a successful partnership with Novo. The company's pipeline, particularly candidates like SEP-631, has the potential to achieve blockbuster status comparable to drugs generating billions in annual sales, thereby underscoring a strong commercial opportunity in the obesity treatment market. Additionally, Septerna's innovative Native Complex Platform and its focus on diverse therapeutic areas suggest robust long-term value creation, enhancing investor confidence in the company's future growth prospects.

Bears say

Septerna Inc. faces several fundamental risks that contribute to a negative outlook on its stock, primarily revolving around potential delays in the clinical development of key candidates such as SEP-631. The company's reliance on strategic partnerships, particularly with Novo Nordisk, raises concerns regarding collaboration stability and future product market penetration. Additionally, the prospect of long-term dilution risk further complicates the financial landscape, as there may be challenges in achieving regulatory approvals and overcoming setbacks in clinical trials.

Septerna Inc (SEPN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Apr 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.